Deborah Yurgelun-Todd

From Wikipedia the free encyclopedia

Deborah Yurgelun-Todd
Academic background
EducationB.A., 1974, Mount Holyoke College
MA, Psychology, 1979, Boston College
M.A. 1986 Psychology, PhD, Neuropsychology, 1988, Harvard University
ThesisFrontal dysfunction in schizophrenia and manic depressive illness (1988)
Academic work
InstitutionsUniversity of Utah

Deborah Ann Yurgelun-Todd is an American neuropsychologist. In 2017, Yurgelun-Todd was appointed the next Director of the University of Utah's Neuroscience Initiative while simultaneously working as the Co-Director of the Diagnostic Neuroimaging Lab.

Early life and education[edit]

Yurgelun-Todd earned her Bachelor of Arts degree from Mount Holyoke College in 1974 before enrolling at Boston College and Harvard University for her Master's degree and PhD.[1]

Career[edit]

In 2017, Yurgelun-Todd agreed to serve as the next Director of the Neuroscience Initiative and continue to work as the Co-Director of the Diagnostic Neuroimaging Lab.[2] While serving as the director of the institution's Cognitive Neuroimaging Laboratory, she collaborated with members of the Utah Utes football to examine the impact of the combination of head trauma and other factors on the physical and mental health of the school's athletes.[3] The following year, Yurgelun-Todd was one of nine researchers to be awarded a grant by the National Institutes of Health to explore the effects of cannabinoids in pain management.[4] During the COVID-19 pandemic, she was one of a few faculty members who wrote an op-ed regarding mental health during the pandemic-caused lockdowns.[5]

References[edit]

  1. ^ "DEBORAH YURGELUN-TODD". neuroscience.med.utah.edu. Retrieved April 22, 2021.
  2. ^ "Deborah Yurgelun-Todd, PhD, Announced as New Director of Neuroscience Initiative". medicine.utah.edu. July 7, 2017. Retrieved April 22, 2021.
  3. ^ Falk, Aaron (July 31, 2017). "Under new Pac-12 initiative and funding, University of Utah researcher studies head trauma in athletes". The Salt Lake Tribune. Retrieved April 22, 2021.
  4. ^ "EXPLORING THE EFFECTS OF CANNABINOIDS IN PAIN MANAGEMENT". uofuhealth.utah.edu. October 1, 2019. Retrieved April 22, 2021.
  5. ^ Fitzgerald, Colleen; Ranshaw, Perry; Prescot, Andrew; Yurgelun-Todd, Deborah; Boxer, Danielle; Kondo, Doug (May 28, 2020). "Experts warn of a suicide surge related to COVID-19. They may be right". deseret.com. Retrieved April 22, 2021.

External links[edit]